Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Tuesday 19th September 2017 from 8.00am to 4.00pm (BST).

During this time our website performance may be temporarily affected. If you have any questions please use the feedback button available under our menu button. We apologise for any inconvenience this might cause and thank you for your patience.

Issue 15, 2017
Previous Article Next Article

Application of a strain rate gradient microfluidic device to von Willebrand's disease screening

Author affiliations


Von Willebrand's disease (VWD) is the most common inherited bleeding disorder caused by either quantitative or qualitative defects of von Willebrand factor (VWF). Current tests for VWD require relatively large blood volumes, have low throughput, are time-consuming, and do not incorporate the physiologically relevant effects of haemodynamic forces. We developed a microfluidic device incorporating micro-contractions that harnesses well-defined haemodynamic strain gradients to initiate platelet aggregation in citrated whole blood. The microchannel architecture has been specifically designed to allow for continuous real-time imaging of platelet aggregation dynamics. Subjects aged ≥18 years with previously diagnosed VWD or who presented for evaluation of a bleeding disorder, where the possible diagnosis included VWD, were tested. Samples were obtained for device characterization as well as for pathology-based testing. Platelet aggregation in the microfluidic device is independent of platelet amplification loops but dependent on low-level platelet activation, GPIb/IX/V and integrin αIIbβ3 engagement. Microfluidic output directly correlates with VWF antigen levels and is able to sensitively detect aggregation defects associated with VWD subtypes. Testing demonstrated a strong correlation with standard clinical laboratory-based tests. Head-to-head comparison with PFA100® demonstrated equivalent, if not improved, sensitivity for screening aggregation defects associated with VWD. This strain rate gradient microfluidic prototype has the potential to be a clinically useful, rapid and high throughput-screening tool for VWD as well as other strain-dependent platelet disorders. In addition, the microfluidic device represents a novel approach to examine the effects of high magnitude/short duration (ms) strain rate gradients on platelet function.

Graphical abstract: Application of a strain rate gradient microfluidic device to von Willebrand's disease screening

Back to tab navigation

Supplementary files

Publication details

The article was received on 09 May 2017, accepted on 21 Jun 2017 and first published on 21 Jun 2017

Article type: Paper
DOI: 10.1039/C7LC00498B
Citation: Lab Chip, 2017,17, 2595-2608
  •   Request permissions

    Application of a strain rate gradient microfluidic device to von Willebrand's disease screening

    R. J. Brazilek, F. J. Tovar-Lopez, A. K. T. Wong, H. Tran, A. S. Davis, J. D. McFadyen, Z. Kaplan, S. Chunilal, S. P. Jackson, H. Nandurkar, A. Mitchell and W. S. Nesbitt, Lab Chip, 2017, 17, 2595
    DOI: 10.1039/C7LC00498B

Search articles by author